Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib vs Methotrexate in Active Takayasu's Arteritis
NCT05102448Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib in Takayasu arteritis (TAK), sponsored by Zhongshan Hospital, Fudan University. Started Nov 2021; status: recruiting.
02
Drugs
03
Conditions
Takayasu arteritis (TAK)
Beyond the preview
Go deeper on NCT05102448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05102448.